Pregnancy Clinical Trial
Official title:
The Effect of Light on the Fetal Biophysical Profile
Verified date | September 2017 |
Source | University of Nebraska |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Since the 1960's, perinatal mortality in the United States has been declining at a steady
rate. This decline has thought to be the result of improved surveillance of normal and
abnormal fetal behavior and using that information to determine those babies at risk for
stillbirth.
There are many tools available for surveillance. One of these tools, the bio-physical profile
(BPP), incorporates a non-stress test (NST) with ultrasound assessment of fetal behavior .
This test has been used for about the last 30 years with good safety and efficacy. The
ultrasound evaluation includes monitoring fetal breathing, fetal gross and fine movement and
amniotic fluid evaluation. NST and BPP have been found to have similar ability to predict
fetal well-being, with similar safety and ease of performance. Several studies have observed
the effect of sound as well as light on the NST and have found that it can shorten testing
time without altering its ability to be interpreted properly or affecting fetal safety.
However, similar studies have not been done with the BPP. Light stimulation has been proven
to be safe for both the mother and the fetus with no harm having been demonstrated when used
with NST.
Status | Completed |
Enrollment | 200 |
Est. completion date | February 2017 |
Est. primary completion date | February 2017 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 14 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Mothers age 14-60 years old with singleton pregnancies at 20 0/7th weeks to 42 6/7th weeks gestational age - Biophysical testing has been ordered for any indication other than higher order multiple gestations. Exclusion Criteria: - Patient declines to participate. - Multiple gestations (twins or more) |
Country | Name | City | State |
---|---|---|---|
United States | St. Mary's Health Center | Saint Louis | Missouri |
Lead Sponsor | Collaborator |
---|---|
University of Nebraska |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Amount of time needed to complete the biophysical profile | Measure if ambient room light stimulation changes the amount of time required to perform the fetal biophysical profile | Patients to be followed from initiation of biophysical profiles until delivery an expected average of 8 weeks) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02379728 -
Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth
|
N/A |